|
End-of-day quote
Shanghai S.E.
2026-08-28
|
5-day change | 1st Jan Change | ||
| 70.38 CNY | -1.40% |
|
-2.07% | +3.39% |
| 08-26 | Gan & Lee Pharma's H1 Profit Rises 1%, Revenue Climbs 8% | MT |
| 08-25 | Gan & Lee Pharmaceuticals Subsidiary Secures China Clinical Trial Nod for Weight Loss Drug | MT |
| Market Cap | 41.89B 6.23B 5.37B 5.03B 4.59B 8.65B 595B 8.68B 59.68B 23.29B 300B 23.38B 22.87B 996B | P/E 2026 * |
30.3x | P/E 2027 * | 26.3x |
|---|---|---|---|---|---|
| Enterprise Value | 38.69B 5.75B 4.95B 4.65B 4.24B 7.99B 550B 8.01B 55.12B 21.5B 277B 21.59B 21.12B 920B | EV / Sales 2026 * |
8.19x | EV / Sales 2027 * | 6.8x |
| Free-Float |
57.83% | Yield 2026 * |
0.34% | Yield 2027 * | 0.38% |
| 1 day | -1.40% | ||
| 1 week | -2.07% | ||
| Current month | +2.40% | ||
| 1 month | +8.80% | ||
| 3 months | +32.34% | ||
| 6 months | +6.68% | ||
| Current year | +3.39% |
| 1 week | 65 |  | 72.99 |
| 1 month | 64.78 | | 79.99 |
| Current year | 51.51 | | 79.99 |
| 1 year | 51.51 | | 82.25 |
| 3 years | 32.1 | | 82.25 |
| 5 years | 30.53 | | 83.38 |
| 10 years | 30.53 | | 204.41 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei Chen
CEO | Chief Executive Officer | 46 | 2025-05-29 |
Qi Wang
DFI | Director of Finance/CFO | 44 | 2026-03-08 |
Ting Jia
CTO | Chief Tech/Sci/R&D Officer | - | 2026-03-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhong Ru Gan
CHM | Chairman | 78 | 1998-06-16 |
Kai Du
BRD | Director/Board Member | 49 | 2009-12-31 |
Wei Qiang Song
BRD | Director/Board Member | 44 | 2015-09-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.40% | -2.07% | +2.79% | +66.19% | 6.32B | |
| -1.67% | -4.78% | +37.02% | -4.42% | 80.65B | |
| -0.90% | +0.65% | -20.11% | -34.58% | 59.9B | |
| -3.35% | -4.92% | +463.91% | +21.22% | 57B | |
| -6.78% | -5.59% | -5.25% | +27.67% | 53.35B | |
| -2.43% | -0.64% | +7.60% | +165.06% | 49.29B | |
| -1.35% | +0.79% | +64.72% | -17.56% | 32.73B | |
| -2.64% | -2.69% | +48.59% | +91.84% | 25.89B | |
| -0.09% | +6.23% | +18.13% | +218.05% | 23.9B | |
| -0.34% | +1.04% | +59.33% | +110.57% | 17.07B | |
| Average | -2.15% | +2.16% | +67.67% | +64.40% | 40.61B | |
| Weighted average by Cap. | -2.51% | +1.11% | +81.65% | +43.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.73B 702M 605M 568M 518M 976M 67.14B 979M 6.73B 2.63B 33.89B 2.64B 2.58B 112B | 5.53B 822M 709M 664M 606M 1.14B 78.59B 1.15B 7.88B 3.08B 39.67B 3.09B 3.02B 132B |
| Net income | 1.39B 206M 178M 167M 152M 287M 19.74B 288M 1.98B 772M 9.96B 775M 758M 33.03B | 1.6B 238M 205M 192M 175M 330M 22.71B 331M 2.28B 889M 11.47B 892M 873M 38.02B |
| Net Debt | -3.2B -476M -410M -385M -351M -661M -45.5B -664M -4.56B -1.78B -22.97B -1.79B -1.75B -76.15B | -4.28B -636M -548M -514M -469M -883M -60.76B -886M -6.09B -2.38B -30.67B -2.39B -2.33B -102B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | CN¥70.38 | -1.40% | 5,504,955 |
| 26-08-27 | CN¥71.38 | +0.11% | 9,478,763 |
| 26-08-26 | CN¥71.30 | +3.66% | 14,975,788 |
| 26-08-25 | CN¥68.78 | +5.06% | 12,908,972 |
| 26-08-24 | CN¥65.47 | -4.33% | 10,725,855 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 603087 Stock
Select your edition
All financial news and data tailored to specific country editions
